# Estrella Immunopharma, Inc. (ESLA): MoatMap facts

As of 27 Oct 2026. Research data, not investment advice.

As of 27 Oct 2026, MoatMap's StockRank for Estrella Immunopharma, Inc. (ESLA) is 2/100, ranked against 24,000+ stocks in 35 markets (Quality 16, Value 25, Momentum 19, each scored against its sector).

- StockRank: 2/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 16, Value 25, Momentum 19: each a 0-100 percentile within Healthcare.
- Position: #26,019 overall, #2,593 in Healthcare.
- Listing: United States, NCM; Healthcare / Biotechnology.
- Last close: 0.919 USD on 26 Oct 2026.
- Insider filings, last 180 days: no director or 5%+ holder trades with a stated value.
- Buybacks, last 180 days: the company bought back USD 1.0M on 1 day.

Source: https://moatmap.ai/stock/ESLA
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker